 |
|
|
|
 |
|||
Here at footnoted, we work for our founding editor, Michelle Leder. And as a tiny outpost of Morningstar Inc., of course, we all ultimately work for founding Chairman and Chief Executive Joe Mansueto. It’s safe to say that we’re happy working for a couple of enterprising visionaries like Joe and Michelle. (Hi, guys!) But a [...]
It usually isn’t seemly for managers to look like they’re treating a public company like their personal fiefdom (or trough). But when a company is still headed by its founder, and where that founder still holds a significant chunk of the shares, are giant paychecks more tolerable, short of outright exploitation? These questions came to [...]
When we posted on Nov. 12 about the flurry of margin calls at Boston Scientific Corp. (BSX), there was no way to know that the pace of involuntary stock sales would continue. As a historical recap: Michelle noted in her post last week that company co-founders Peter Nicholas and John Abele sold off over 30 [...]
It’s been a little over a year since we last saw a margin call at Boston Scientific. But on Monday and again on Tuesday, we spotted two Form 4s filed by one of the company’s co-founders, Peter Nicholas, who is also a director. On Nov. 5, Nicholas sold 250,000 shares of company stock and the [...]
RSS
